SlideShare a Scribd company logo
1 of 11
Quality Innovation
ResultsPartnership
Welcome to BBI Solutions
“Our vision is to create
a world where
everyone has the
opportunity for a
better quality of life”
 Leading experts in immunoassay
development and manufacturing services
 Leading supplier of critical biological raw
materials and labels
 Served the global diagnostics industry for
over 50 years
 BBI Solutions is the partner you can rely
on to deliver the results you need
Introducing BBI Solutions
So, how did we get here?
1959
1986
1996
2000
2007
2010
2013
Now
Seravac, the oldest company within BBI
Solutions was founded
John Chandler of Cardiff University founded
BBI, the foundation of our group
Our gold nanoparticles were first used in
the IVD Market
Our first major lateral flow development
for Merck was secured and delivered
Biozyme and Seravac acquired, expanding
our enzyme manufacturing capabilities
SCIPAC was acquired, introducing human
proteins into the product portfolio
We rebranded to bring our complete
offering together as BBI Solutions
Over 500 experienced staff, introducing
new innovation to the IVD industry
Biozyme Laboratories established as a
manufacturer of diagnostic enzymes
1971
A Global Footprint
Growth: £900,000 turnover to
£37M in 14 years. £53M Group
Quality: ISO13485 and ISO9001
certified sites. FDA and ANVISA
registered sites
Expertise: Over 500 employees
Secure Supply: Sites in 5
different countries
Partnership
Innovation
Results
Quality
Let our values work for you
“Have
confidence in
your assay
performance
with the
security of
using highest
quality
materials
“Save time
and money by
consulting with
our technical
team – Flexible
purchase
plans”
“Beat the
competition by
using our new
and optimised
technology in
your next
assay”
“Get the same
result with every
batch thanks to
our certified
quality systems”
 We understand the challenges our
customers face when developing a new
product – we do it ourselves every day!
 This puts us in a unique position to tackle
the BIG issues for you:
 Next generation technology
 Innovating and customising
 Increasing speed to market
 Continuous supply
 Improving cost effectiveness
 Faster more sensitive results
And take advantage of our experience
“I have been optimising
diagnostic assays for 40
years with BBI – use my
experience to improve
your diagnostic results”
High quality products and services
 Human Proteins
 Antibodies
 Enzymes
 Disease State Plasma
 Depleted Serum
 Gold Nanoparticles
 Custom Conjugation
 Lateral Flow Development and
Optimisation
 Lateral Flow Manufacturing
 Sensitivity enhancement technology
 Integrated platform – AtomoRapid™
Contract Services
Biological Raw Materials
Introducing our flagship raw materials
“Our Glucose
Oxidase powers
over 5 billion
BGM test strips
every year”
Our ‘World best’
Enzymes
+ Glucose Oxidase
+ FAD - GDH
+ Alkaline Phosphatase
+ Horseradish Peroxidase
+ Urease
“BBI’s gold is the
most consistent
available and
supports over
400 million lateral
flow assays every
year”
Our Gold
+ 2nm to 250nm
+ High OD available
+ Up to >95% mono dispersity
+ <8% CV
“Our CRP Fab
antibody
outperforms
market leading
reagents in
lateral flow”
Our Antibodies
+ D-Dimer
+ Dengue Subtype 2
+ Calcitonin Fab mAb
+ CRP Fab mAb
“Our proteins go
into hundreds of
controls to ensure
accurate
diagnostic
results”
Our ‘Best in class’
Proteins
+ TBG
+ B2M
+ Tg
+ CRP
Our world renowned development service
“We have successfully
completed more than
250 different lateral flow
projects, 12 of these are
FDA cleared”
 Over 25 years experience developing
lateral flow assays, BBI Solutions is a
name you can trust
 Quality - FDA and ANVISA registered
manufacturing sites. ISO13485 and ISO
9001 certified QMS systems across all
sites
 Sensitivity enhancement technology,
powering 2nd generation assays
 The design history folder belongs to you
 Getting you to market quickly, we care
about your results for the long term
Innovative new products in 2014
Revolutionary reader technology – our Novarum
Handheld reader solution brings lateral flow and
mobile technology together.
Our R&D teams are currently utilising 3DNA technology,
developing enhanced particles and enhance signal
methods and utilising new recombinant antibodies.
Our new recombinant proteins are future proof by
eliminating any supply sustainability issues.
Recombinant NGAL, Cystatin C and Transferrin are all
currently in development.
A long term partnership
 Dedicated account & technical support
 Long term collaborative partnerships
 Highest quality biological materials and
components
 Access to the latest innovative technologies
 Quality systems conforming to all regulatory
requirements
 Faster, more accurate, more sensitive results
using high performance products and services
“BBI´s commitment and
professionalism were key
points to achieve the
successful result in gaining
the GMP Certificate”
Ingrid Jurgensen, Compliance Auditor at
Becton Dickinson
 A partner who understands and will support you

More Related Content

What's hot

KRS_brochure_042115_pf_webready (3)
KRS_brochure_042115_pf_webready (3)KRS_brochure_042115_pf_webready (3)
KRS_brochure_042115_pf_webready (3)Stephen Duffie
 
General presentation XB
General presentation XBGeneral presentation XB
General presentation XBAmlieJanssen
 
HJB CDMO Introduction (2019)
HJB CDMO Introduction (2019)HJB CDMO Introduction (2019)
HJB CDMO Introduction (2019)XiaomingJerryYang
 
Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...
Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...
Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...MilliporeSigma
 
Research &amp; development services
Research &amp; development services Research &amp; development services
Research &amp; development services DionJusty
 
Mobilus Health Overview
Mobilus Health OverviewMobilus Health Overview
Mobilus Health OverviewRicky Kim
 
Commercializing antibody-drug conjugates: a CMO’s journey
Commercializing antibody-drug conjugates: a CMO’s journeyCommercializing antibody-drug conjugates: a CMO’s journey
Commercializing antibody-drug conjugates: a CMO’s journeyMerck Life Sciences
 
Multiplexing and Arraying in Lateral Flow Assays
Multiplexing and Arraying in Lateral Flow AssaysMultiplexing and Arraying in Lateral Flow Assays
Multiplexing and Arraying in Lateral Flow AssaysBrendan O'Farrell
 
A Molecule’s Journey – Breaking Down Roadblocks to Commercial Success
A Molecule’s Journey – Breaking Down Roadblocks to Commercial SuccessA Molecule’s Journey – Breaking Down Roadblocks to Commercial Success
A Molecule’s Journey – Breaking Down Roadblocks to Commercial SuccessMilliporeSigma
 
Kurtz biomanufacturing
Kurtz biomanufacturingKurtz biomanufacturing
Kurtz biomanufacturingbio-link
 
Extractables profiles for chromatography resins - adapted approach of upcomin...
Extractables profiles for chromatography resins - adapted approach of upcomin...Extractables profiles for chromatography resins - adapted approach of upcomin...
Extractables profiles for chromatography resins - adapted approach of upcomin...MilliporeSigma
 
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...Merck Life Sciences
 
Covering a Spectrum of New Product Development Technologies - From Cells to C...
Covering a Spectrum of New Product Development Technologies - From Cells to C...Covering a Spectrum of New Product Development Technologies - From Cells to C...
Covering a Spectrum of New Product Development Technologies - From Cells to C...KBI Biopharma
 
(2014) Quazar Data Acquisition Systems
(2014) Quazar Data Acquisition Systems (2014) Quazar Data Acquisition Systems
(2014) Quazar Data Acquisition Systems Shashank Chintalagiri
 
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationEU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationMilliporeSigma
 
Biodextris Presentation - New client presentation
Biodextris Presentation - New client presentationBiodextris Presentation - New client presentation
Biodextris Presentation - New client presentationJoseph Zimmermann
 
From preclinical to commercial: The evolution of ADC manufacturing expertise ...
From preclinical to commercial: The evolution of ADC manufacturing expertise ...From preclinical to commercial: The evolution of ADC manufacturing expertise ...
From preclinical to commercial: The evolution of ADC manufacturing expertise ...MilliporeSigma
 

What's hot (20)

KRS_brochure_042115_pf_webready (3)
KRS_brochure_042115_pf_webready (3)KRS_brochure_042115_pf_webready (3)
KRS_brochure_042115_pf_webready (3)
 
General presentation XB
General presentation XBGeneral presentation XB
General presentation XB
 
Stabicon-Corporate presentation
Stabicon-Corporate presentationStabicon-Corporate presentation
Stabicon-Corporate presentation
 
Gene Therapy Services
Gene Therapy ServicesGene Therapy Services
Gene Therapy Services
 
HJB CDMO Introduction (2019)
HJB CDMO Introduction (2019)HJB CDMO Introduction (2019)
HJB CDMO Introduction (2019)
 
Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...
Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...
Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...
 
Research &amp; development services
Research &amp; development services Research &amp; development services
Research &amp; development services
 
Mobilus Health Overview
Mobilus Health OverviewMobilus Health Overview
Mobilus Health Overview
 
Commercializing antibody-drug conjugates: a CMO’s journey
Commercializing antibody-drug conjugates: a CMO’s journeyCommercializing antibody-drug conjugates: a CMO’s journey
Commercializing antibody-drug conjugates: a CMO’s journey
 
Cell line development services
Cell line development servicesCell line development services
Cell line development services
 
Multiplexing and Arraying in Lateral Flow Assays
Multiplexing and Arraying in Lateral Flow AssaysMultiplexing and Arraying in Lateral Flow Assays
Multiplexing and Arraying in Lateral Flow Assays
 
A Molecule’s Journey – Breaking Down Roadblocks to Commercial Success
A Molecule’s Journey – Breaking Down Roadblocks to Commercial SuccessA Molecule’s Journey – Breaking Down Roadblocks to Commercial Success
A Molecule’s Journey – Breaking Down Roadblocks to Commercial Success
 
Kurtz biomanufacturing
Kurtz biomanufacturingKurtz biomanufacturing
Kurtz biomanufacturing
 
Extractables profiles for chromatography resins - adapted approach of upcomin...
Extractables profiles for chromatography resins - adapted approach of upcomin...Extractables profiles for chromatography resins - adapted approach of upcomin...
Extractables profiles for chromatography resins - adapted approach of upcomin...
 
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
 
Covering a Spectrum of New Product Development Technologies - From Cells to C...
Covering a Spectrum of New Product Development Technologies - From Cells to C...Covering a Spectrum of New Product Development Technologies - From Cells to C...
Covering a Spectrum of New Product Development Technologies - From Cells to C...
 
(2014) Quazar Data Acquisition Systems
(2014) Quazar Data Acquisition Systems (2014) Quazar Data Acquisition Systems
(2014) Quazar Data Acquisition Systems
 
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationEU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
 
Biodextris Presentation - New client presentation
Biodextris Presentation - New client presentationBiodextris Presentation - New client presentation
Biodextris Presentation - New client presentation
 
From preclinical to commercial: The evolution of ADC manufacturing expertise ...
From preclinical to commercial: The evolution of ADC manufacturing expertise ...From preclinical to commercial: The evolution of ADC manufacturing expertise ...
From preclinical to commercial: The evolution of ADC manufacturing expertise ...
 

Viewers also liked

BBI Solutions - Human Proteins
BBI Solutions - Human ProteinsBBI Solutions - Human Proteins
BBI Solutions - Human ProteinsBBISolutions
 
BBI Solutions - Antibodies
BBI Solutions - AntibodiesBBI Solutions - Antibodies
BBI Solutions - AntibodiesBBISolutions
 
BBI Solutions - Enzymes
BBI Solutions - EnzymesBBI Solutions - Enzymes
BBI Solutions - EnzymesBBISolutions
 
BBI Solutions - Nanoparticles
BBI Solutions - NanoparticlesBBI Solutions - Nanoparticles
BBI Solutions - NanoparticlesBBISolutions
 
Disease State Plasma
Disease State PlasmaDisease State Plasma
Disease State PlasmaBBISolutions
 
April 2015 - Disease State Plasma Newsflash - BBI Solutions
April 2015 - Disease State Plasma Newsflash - BBI SolutionsApril 2015 - Disease State Plasma Newsflash - BBI Solutions
April 2015 - Disease State Plasma Newsflash - BBI SolutionsBBISolutions
 

Viewers also liked (6)

BBI Solutions - Human Proteins
BBI Solutions - Human ProteinsBBI Solutions - Human Proteins
BBI Solutions - Human Proteins
 
BBI Solutions - Antibodies
BBI Solutions - AntibodiesBBI Solutions - Antibodies
BBI Solutions - Antibodies
 
BBI Solutions - Enzymes
BBI Solutions - EnzymesBBI Solutions - Enzymes
BBI Solutions - Enzymes
 
BBI Solutions - Nanoparticles
BBI Solutions - NanoparticlesBBI Solutions - Nanoparticles
BBI Solutions - Nanoparticles
 
Disease State Plasma
Disease State PlasmaDisease State Plasma
Disease State Plasma
 
April 2015 - Disease State Plasma Newsflash - BBI Solutions
April 2015 - Disease State Plasma Newsflash - BBI SolutionsApril 2015 - Disease State Plasma Newsflash - BBI Solutions
April 2015 - Disease State Plasma Newsflash - BBI Solutions
 

Similar to BBI Solutions

GVK BIO Corporate Brochure 2017
GVK BIO Corporate Brochure 2017 GVK BIO Corporate Brochure 2017
GVK BIO Corporate Brochure 2017 GVK Biosciences
 
2018 Thermo Fisher Scientific Company Overview
2018 Thermo Fisher Scientific Company Overview2018 Thermo Fisher Scientific Company Overview
2018 Thermo Fisher Scientific Company OverviewJulie Good Harmon
 
2016 Thermo Fisher Scientific Company Overview
2016 Thermo Fisher Scientific Company Overview2016 Thermo Fisher Scientific Company Overview
2016 Thermo Fisher Scientific Company OverviewJosie Zheng
 
Zee Company Food & Beverage Services
Zee Company Food & Beverage Services Zee Company Food & Beverage Services
Zee Company Food & Beverage Services The Vincit Group
 
2019 Thermo Fisher Scientific Company Overview
2019 Thermo Fisher Scientific Company Overview2019 Thermo Fisher Scientific Company Overview
2019 Thermo Fisher Scientific Company OverviewJulie Good Harmon
 
Biovays Discovery Summit Presentation
Biovays Discovery Summit PresentationBiovays Discovery Summit Presentation
Biovays Discovery Summit PresentationIguanaBio Iguana
 
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...Business Turku
 
For those interested in Healthcare Fieldwork services - please take a look!
For those interested in Healthcare Fieldwork services - please take a look!For those interested in Healthcare Fieldwork services - please take a look!
For those interested in Healthcare Fieldwork services - please take a look!Paul Morgan
 
Dcn inovatec presentation final
Dcn inovatec presentation finalDcn inovatec presentation final
Dcn inovatec presentation finalFabiana Tarabal
 
Sterilpharma Sdn. Bhd. Seminar Intro
Sterilpharma Sdn. Bhd. Seminar IntroSterilpharma Sdn. Bhd. Seminar Intro
Sterilpharma Sdn. Bhd. Seminar IntroUwe Freitag
 
Alembic Pharma: Secure and Leverages Email data with Archival and Ediscovery
Alembic Pharma: Secure and Leverages Email data with Archival and Ediscovery Alembic Pharma: Secure and Leverages Email data with Archival and Ediscovery
Alembic Pharma: Secure and Leverages Email data with Archival and Ediscovery Vaultastic
 
Welcome to the Vincit Group
Welcome to the Vincit Group Welcome to the Vincit Group
Welcome to the Vincit Group The Vincit Group
 
Sa Corp Presentation(6.17.09)
Sa Corp Presentation(6.17.09)Sa Corp Presentation(6.17.09)
Sa Corp Presentation(6.17.09)Dafna Shelly
 
An introduction to BSI.
An introduction to BSI.An introduction to BSI.
An introduction to BSI.Normdocs
 

Similar to BBI Solutions (20)

GVK BIO Corporate Brochure 2017
GVK BIO Corporate Brochure 2017 GVK BIO Corporate Brochure 2017
GVK BIO Corporate Brochure 2017
 
2018 Thermo Fisher Scientific Company Overview
2018 Thermo Fisher Scientific Company Overview2018 Thermo Fisher Scientific Company Overview
2018 Thermo Fisher Scientific Company Overview
 
2016 Thermo Fisher Scientific Company Overview
2016 Thermo Fisher Scientific Company Overview2016 Thermo Fisher Scientific Company Overview
2016 Thermo Fisher Scientific Company Overview
 
Brochure
BrochureBrochure
Brochure
 
Zee Company Food & Beverage Services
Zee Company Food & Beverage Services Zee Company Food & Beverage Services
Zee Company Food & Beverage Services
 
2019 Thermo Fisher Scientific Company Overview
2019 Thermo Fisher Scientific Company Overview2019 Thermo Fisher Scientific Company Overview
2019 Thermo Fisher Scientific Company Overview
 
RANDOX Company overview (4).pdf
RANDOX   Company overview (4).pdfRANDOX   Company overview (4).pdf
RANDOX Company overview (4).pdf
 
Progamma Us
Progamma UsProgamma Us
Progamma Us
 
Biovays Discovery Summit Presentation
Biovays Discovery Summit PresentationBiovays Discovery Summit Presentation
Biovays Discovery Summit Presentation
 
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
 
For those interested in Healthcare Fieldwork services - please take a look!
For those interested in Healthcare Fieldwork services - please take a look!For those interested in Healthcare Fieldwork services - please take a look!
For those interested in Healthcare Fieldwork services - please take a look!
 
Dcn inovatec presentation final
Dcn inovatec presentation finalDcn inovatec presentation final
Dcn inovatec presentation final
 
Sterilpharma Sdn. Bhd. Seminar Intro
Sterilpharma Sdn. Bhd. Seminar IntroSterilpharma Sdn. Bhd. Seminar Intro
Sterilpharma Sdn. Bhd. Seminar Intro
 
Alembic Pharma: Secure and Leverages Email data with Archival and Ediscovery
Alembic Pharma: Secure and Leverages Email data with Archival and Ediscovery Alembic Pharma: Secure and Leverages Email data with Archival and Ediscovery
Alembic Pharma: Secure and Leverages Email data with Archival and Ediscovery
 
NCPI Brochure
NCPI BrochureNCPI Brochure
NCPI Brochure
 
BioDuro
BioDuro BioDuro
BioDuro
 
Welcome to the Vincit Group
Welcome to the Vincit Group Welcome to the Vincit Group
Welcome to the Vincit Group
 
Forward1
Forward1Forward1
Forward1
 
Sa Corp Presentation(6.17.09)
Sa Corp Presentation(6.17.09)Sa Corp Presentation(6.17.09)
Sa Corp Presentation(6.17.09)
 
An introduction to BSI.
An introduction to BSI.An introduction to BSI.
An introduction to BSI.
 

More from BBISolutions

Clinical Samples & Disease State Plasma Newsflash October 2016
Clinical Samples & Disease State Plasma Newsflash October 2016Clinical Samples & Disease State Plasma Newsflash October 2016
Clinical Samples & Disease State Plasma Newsflash October 2016BBISolutions
 
Clinical Samples & Disease State Plasma Newsflash October 2016 final
Clinical Samples & Disease State Plasma Newsflash October 2016 finalClinical Samples & Disease State Plasma Newsflash October 2016 final
Clinical Samples & Disease State Plasma Newsflash October 2016 finalBBISolutions
 
September 2015 - Antibodies Newsflash - BBI Solutions
September 2015 - Antibodies Newsflash - BBI SolutionsSeptember 2015 - Antibodies Newsflash - BBI Solutions
September 2015 - Antibodies Newsflash - BBI SolutionsBBISolutions
 
Antibodies - Key Marker Performance - July 2015
Antibodies - Key Marker Performance - July 2015Antibodies - Key Marker Performance - July 2015
Antibodies - Key Marker Performance - July 2015BBISolutions
 
May 2015 Antibodies Newsflash - BBI Solutions
May 2015 Antibodies Newsflash - BBI SolutionsMay 2015 Antibodies Newsflash - BBI Solutions
May 2015 Antibodies Newsflash - BBI SolutionsBBISolutions
 
January 2015 antibodies newsflash
January 2015   antibodies newsflashJanuary 2015   antibodies newsflash
January 2015 antibodies newsflashBBISolutions
 
January 2015 - Antibodies Newsflash
January 2015 - Antibodies NewsflashJanuary 2015 - Antibodies Newsflash
January 2015 - Antibodies NewsflashBBISolutions
 
Antibodies Newsflash - September 2014 - BBI Solutions
Antibodies Newsflash - September 2014 - BBI SolutionsAntibodies Newsflash - September 2014 - BBI Solutions
Antibodies Newsflash - September 2014 - BBI SolutionsBBISolutions
 
Disease State Plasma Newsflash - August 2014 - BBI Solutions
Disease State Plasma Newsflash - August 2014 - BBI SolutionsDisease State Plasma Newsflash - August 2014 - BBI Solutions
Disease State Plasma Newsflash - August 2014 - BBI SolutionsBBISolutions
 
April 2014 - Antibodies Newsflash - BBI Solutions
April 2014 - Antibodies Newsflash - BBI SolutionsApril 2014 - Antibodies Newsflash - BBI Solutions
April 2014 - Antibodies Newsflash - BBI SolutionsBBISolutions
 
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI SolutionsDisease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI SolutionsBBISolutions
 

More from BBISolutions (11)

Clinical Samples & Disease State Plasma Newsflash October 2016
Clinical Samples & Disease State Plasma Newsflash October 2016Clinical Samples & Disease State Plasma Newsflash October 2016
Clinical Samples & Disease State Plasma Newsflash October 2016
 
Clinical Samples & Disease State Plasma Newsflash October 2016 final
Clinical Samples & Disease State Plasma Newsflash October 2016 finalClinical Samples & Disease State Plasma Newsflash October 2016 final
Clinical Samples & Disease State Plasma Newsflash October 2016 final
 
September 2015 - Antibodies Newsflash - BBI Solutions
September 2015 - Antibodies Newsflash - BBI SolutionsSeptember 2015 - Antibodies Newsflash - BBI Solutions
September 2015 - Antibodies Newsflash - BBI Solutions
 
Antibodies - Key Marker Performance - July 2015
Antibodies - Key Marker Performance - July 2015Antibodies - Key Marker Performance - July 2015
Antibodies - Key Marker Performance - July 2015
 
May 2015 Antibodies Newsflash - BBI Solutions
May 2015 Antibodies Newsflash - BBI SolutionsMay 2015 Antibodies Newsflash - BBI Solutions
May 2015 Antibodies Newsflash - BBI Solutions
 
January 2015 antibodies newsflash
January 2015   antibodies newsflashJanuary 2015   antibodies newsflash
January 2015 antibodies newsflash
 
January 2015 - Antibodies Newsflash
January 2015 - Antibodies NewsflashJanuary 2015 - Antibodies Newsflash
January 2015 - Antibodies Newsflash
 
Antibodies Newsflash - September 2014 - BBI Solutions
Antibodies Newsflash - September 2014 - BBI SolutionsAntibodies Newsflash - September 2014 - BBI Solutions
Antibodies Newsflash - September 2014 - BBI Solutions
 
Disease State Plasma Newsflash - August 2014 - BBI Solutions
Disease State Plasma Newsflash - August 2014 - BBI SolutionsDisease State Plasma Newsflash - August 2014 - BBI Solutions
Disease State Plasma Newsflash - August 2014 - BBI Solutions
 
April 2014 - Antibodies Newsflash - BBI Solutions
April 2014 - Antibodies Newsflash - BBI SolutionsApril 2014 - Antibodies Newsflash - BBI Solutions
April 2014 - Antibodies Newsflash - BBI Solutions
 
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI SolutionsDisease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
 

Recently uploaded

GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxAleenaTreesaSaji
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptxanandsmhk
 
Broad bean, Lima Bean, Jack bean, Ullucus.pptx
Broad bean, Lima Bean, Jack bean, Ullucus.pptxBroad bean, Lima Bean, Jack bean, Ullucus.pptx
Broad bean, Lima Bean, Jack bean, Ullucus.pptxjana861314
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Nistarini College, Purulia (W.B) India
 
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |aasikanpl
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bSérgio Sacani
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
Formation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksFormation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksSérgio Sacani
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsAArockiyaNisha
 
Cultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxCultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxpradhanghanshyam7136
 
Chemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdfChemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdfSumit Kumar yadav
 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfSumit Kumar yadav
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real timeSatoshi NAKAHIRA
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Patrick Diehl
 
Boyles law module in the grade 10 science
Boyles law module in the grade 10 scienceBoyles law module in the grade 10 science
Boyles law module in the grade 10 sciencefloriejanemacaya1
 
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...ssifa0344
 
Botany 4th semester series (krishna).pdf
Botany 4th semester series (krishna).pdfBotany 4th semester series (krishna).pdf
Botany 4th semester series (krishna).pdfSumit Kumar yadav
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...jana861314
 

Recently uploaded (20)

GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptx
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
 
Broad bean, Lima Bean, Jack bean, Ullucus.pptx
Broad bean, Lima Bean, Jack bean, Ullucus.pptxBroad bean, Lima Bean, Jack bean, Ullucus.pptx
Broad bean, Lima Bean, Jack bean, Ullucus.pptx
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...
 
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
Formation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksFormation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disks
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
 
Cultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptxCultivation of KODO MILLET . made by Ghanshyam pptx
Cultivation of KODO MILLET . made by Ghanshyam pptx
 
Chemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdfChemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdf
 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdf
 
CELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdfCELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdf
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real time
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?
 
Boyles law module in the grade 10 science
Boyles law module in the grade 10 scienceBoyles law module in the grade 10 science
Boyles law module in the grade 10 science
 
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
 
Botany 4th semester series (krishna).pdf
Botany 4th semester series (krishna).pdfBotany 4th semester series (krishna).pdf
Botany 4th semester series (krishna).pdf
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
 

BBI Solutions

  • 2. “Our vision is to create a world where everyone has the opportunity for a better quality of life”  Leading experts in immunoassay development and manufacturing services  Leading supplier of critical biological raw materials and labels  Served the global diagnostics industry for over 50 years  BBI Solutions is the partner you can rely on to deliver the results you need Introducing BBI Solutions
  • 3. So, how did we get here? 1959 1986 1996 2000 2007 2010 2013 Now Seravac, the oldest company within BBI Solutions was founded John Chandler of Cardiff University founded BBI, the foundation of our group Our gold nanoparticles were first used in the IVD Market Our first major lateral flow development for Merck was secured and delivered Biozyme and Seravac acquired, expanding our enzyme manufacturing capabilities SCIPAC was acquired, introducing human proteins into the product portfolio We rebranded to bring our complete offering together as BBI Solutions Over 500 experienced staff, introducing new innovation to the IVD industry Biozyme Laboratories established as a manufacturer of diagnostic enzymes 1971
  • 4. A Global Footprint Growth: £900,000 turnover to £37M in 14 years. £53M Group Quality: ISO13485 and ISO9001 certified sites. FDA and ANVISA registered sites Expertise: Over 500 employees Secure Supply: Sites in 5 different countries
  • 5. Partnership Innovation Results Quality Let our values work for you “Have confidence in your assay performance with the security of using highest quality materials “Save time and money by consulting with our technical team – Flexible purchase plans” “Beat the competition by using our new and optimised technology in your next assay” “Get the same result with every batch thanks to our certified quality systems”
  • 6.  We understand the challenges our customers face when developing a new product – we do it ourselves every day!  This puts us in a unique position to tackle the BIG issues for you:  Next generation technology  Innovating and customising  Increasing speed to market  Continuous supply  Improving cost effectiveness  Faster more sensitive results And take advantage of our experience “I have been optimising diagnostic assays for 40 years with BBI – use my experience to improve your diagnostic results”
  • 7. High quality products and services  Human Proteins  Antibodies  Enzymes  Disease State Plasma  Depleted Serum  Gold Nanoparticles  Custom Conjugation  Lateral Flow Development and Optimisation  Lateral Flow Manufacturing  Sensitivity enhancement technology  Integrated platform – AtomoRapid™ Contract Services Biological Raw Materials
  • 8. Introducing our flagship raw materials “Our Glucose Oxidase powers over 5 billion BGM test strips every year” Our ‘World best’ Enzymes + Glucose Oxidase + FAD - GDH + Alkaline Phosphatase + Horseradish Peroxidase + Urease “BBI’s gold is the most consistent available and supports over 400 million lateral flow assays every year” Our Gold + 2nm to 250nm + High OD available + Up to >95% mono dispersity + <8% CV “Our CRP Fab antibody outperforms market leading reagents in lateral flow” Our Antibodies + D-Dimer + Dengue Subtype 2 + Calcitonin Fab mAb + CRP Fab mAb “Our proteins go into hundreds of controls to ensure accurate diagnostic results” Our ‘Best in class’ Proteins + TBG + B2M + Tg + CRP
  • 9. Our world renowned development service “We have successfully completed more than 250 different lateral flow projects, 12 of these are FDA cleared”  Over 25 years experience developing lateral flow assays, BBI Solutions is a name you can trust  Quality - FDA and ANVISA registered manufacturing sites. ISO13485 and ISO 9001 certified QMS systems across all sites  Sensitivity enhancement technology, powering 2nd generation assays  The design history folder belongs to you  Getting you to market quickly, we care about your results for the long term
  • 10. Innovative new products in 2014 Revolutionary reader technology – our Novarum Handheld reader solution brings lateral flow and mobile technology together. Our R&D teams are currently utilising 3DNA technology, developing enhanced particles and enhance signal methods and utilising new recombinant antibodies. Our new recombinant proteins are future proof by eliminating any supply sustainability issues. Recombinant NGAL, Cystatin C and Transferrin are all currently in development.
  • 11. A long term partnership  Dedicated account & technical support  Long term collaborative partnerships  Highest quality biological materials and components  Access to the latest innovative technologies  Quality systems conforming to all regulatory requirements  Faster, more accurate, more sensitive results using high performance products and services “BBI´s commitment and professionalism were key points to achieve the successful result in gaining the GMP Certificate” Ingrid Jurgensen, Compliance Auditor at Becton Dickinson  A partner who understands and will support you